Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
11/28/2012 | EP2527340A1 Piperazine compound having a pgds inhibitory effect |
11/28/2012 | EP2527337A1 Inhibitors of 11-beta hydroxysteroid dehydrogenase type I |
11/28/2012 | EP2527326A1 Novel compounds having 4-pyridylalkylthio group as substituent |
11/28/2012 | EP2527315A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease |
11/28/2012 | EP2526783A1 Natural high-potency sweetener compositions with improved temporal profile and/or flavor profile, methods for their formulation, and uses |
11/28/2012 | EP2526097A1 Pyrazine derivatives |
11/28/2012 | EP2526096A1 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds |
11/28/2012 | EP2526089A2 A method of industrial production of an amorphous form of atorvastatin with a high specific surface area and its use in a dosage form |
11/28/2012 | EP2526084A1 Salicylate fatty acid derivatives |
11/28/2012 | EP2525814A2 Methods of treating or preventing periodontitis and diseases associated with periodontitis |
11/28/2012 | EP2525807A1 Pharmaceutical composition for treating a metabolic syndrome |
11/28/2012 | EP2525791A2 Special composition for the use thereof as a drug |
11/28/2012 | CN202554514U Calcium ion powder capsule |
11/28/2012 | CN102803474A Beta-cell replication promoting compounds and methods of their use |
11/28/2012 | CN102803269A Thieno [2,3-b] pyridinedione activators of AMPK and therapeutic uses thereof |
11/28/2012 | CN102803268A Histamine H3 inverse agonists and antagonists and methods of use thereof |
11/28/2012 | CN102803247A Novel fumarate salts of a histamine H3 receptor antagonist |
11/28/2012 | CN102803223A Cyclic compound having substituted phenyl group |
11/28/2012 | CN102802657A GLP-1 and FGF21 combinations for treatment of diabetes type 2 |
11/28/2012 | CN102802653A Decolorized extracts of the plant pandanus conoideus |
11/28/2012 | CN102802652A Composition containing a bean extract for improving blood circulation and increasing vascular health |
11/28/2012 | CN102802651A Pharmaceutical composition for treating diabetes containing quamoclit angulata extracts |
11/28/2012 | CN102802632A Pharmaceutical composition comprising a pyrimidineone derivative |
11/28/2012 | CN102802618A Therapeutic Combinations Of Nicotinic Acid And Meldonium |
11/28/2012 | CN102802428A Copepod oil composition, formulations comprising the oil composition, and the use thereof to reduce accumulation of visceral fat, improve glucose tolerance, and prevent or treat obesity related diseases and disorders |
11/28/2012 | CN102796698A Method for inducing differentiation of placenta-derived mesenchymal stem cells into islet-like cells |
11/28/2012 | CN102796192A Human glucagon-like peptide-1 analogue |
11/28/2012 | CN102796161A Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors |
11/28/2012 | CN102796160A 17ss-hsd1 and sts inhibitors |
11/28/2012 | CN102796159A Dammarane glucosides and preparation method and application thereof |
11/28/2012 | CN102796112A Prenylflavonoid compound and application thereof in preparation of pancrelipase inhibitor |
11/28/2012 | CN102796103A 6-(aryl formyl) imidazo [1,2-a] pyrimidine and 6-(aryl formyl) [1,2,4] triazol [4,3-a] pyrimidine serving as Hedgehog inhibitors and application thereof |
11/28/2012 | CN102796100A Substituted phenyl-(diazaspiro-N)-ketone derivative |
11/28/2012 | CN102796077A Compound with diuretic effect |
11/28/2012 | CN102796075A Benzocycloheptenes derivative as well as preparation method and medical application thereof |
11/28/2012 | CN102796073A Method for preparing (R)-alpha-lipoate and preparation thereof, and application of tablet pharmaceutical composition containing (R)-alpha-lipoate |
11/28/2012 | CN102793900A Antitumor nutritional support medicine composition and preparation method thereof |
11/28/2012 | CN102793891A Traditional Chinese medicine composition having functions of reducing blood fat and resisting hyperuricemia |
11/28/2012 | CN102793847A Non-sulfured processing method of polygonatum |
11/28/2012 | CN102793835A Chinese herbal medicine formula and preparation method thereof |
11/28/2012 | CN102793818A Atractylodes and largehead atractylodes rhizome oral liquid |
11/28/2012 | CN102793810A Blood acidity and alkalinity balancing agent |
11/28/2012 | CN102793809A Chinese herbal medicinal ointment for dredging meridians and removing toxin |
11/28/2012 | CN102793799A Buccal tablets with weight reduction effect |
11/28/2012 | CN102793798A Medicinal composition for auxiliary treatment of diabetic coronary artery disease |
11/28/2012 | CN102793794A Medicinal composition for treating diabetes mellitus and preparation method thereof |
11/28/2012 | CN102793768A Ginseng-ganodorma lucidum meridian-dredging capsule and production process thereof |
11/28/2012 | CN102793756A Preparation process of polygonum multiflorum medicinal slices |
11/28/2012 | CN102793734A Novel medicament for treating cardio-cerebrovascular diseases and preparation method |
11/28/2012 | CN102793733A Ginseng royal jelly chewable tablets and preparation method thereof |
11/28/2012 | CN102793723A Superfine grinding method for animal used as medicine |
11/28/2012 | CN102793720A Method for solving crystal substance precipitation of mixed sugar electrolyte injection after disinfection |
11/28/2012 | CN102793716A Application of aliphatic amine polymer, as well as medicinal composition and preparation method thereof |
11/28/2012 | CN102793714A Application of mecobalamine and analogue to protein tyrosine phosphatases SHP-1 inhibitor |
11/28/2012 | CN102793711A Application of isoquercitrin and analogue thereof to dipeptidyl peptidase IV (DPP-IV) inhibitor |
11/28/2012 | CN102793706A Preparation method of tolvaptan solid dispersion |
11/28/2012 | CN102793662A Probucol nano suspension and preparation method thereof |
11/28/2012 | CN102792947A Cryopreservation liquid and injection of mesenchymal stem cells |
11/28/2012 | CN102342935B Berberine-phenylacetic acid derivative, pharmaceutically acceptable salt thereof and application thereof |
11/28/2012 | CN102293847B Chinese medicinal composition for treating constipation, acne and hyperlipidemia, and preparation method |
11/28/2012 | CN102283973B Traditional Chinese medicine plaster for treating benign tumor and reducing weight and preparation method thereof |
11/28/2012 | CN102274244B Cassia bark polyphenol extract and preparation method and application thereof |
11/28/2012 | CN102178873B Chinese medicine weight-losing preparation comprising external preparation and internal preparation and preparation method thereof |
11/28/2012 | CN102085355B Liraglutide long-acting microsphere injection and preparation method thereof |
11/28/2012 | CN102000123B Ginkgo flavone capsule and preparation method thereof |
11/28/2012 | CN101801371B Process for the preparation of compounds useful as inhibitors of sglt |
11/28/2012 | CN101797371B Drug combination for weight-reducing massage |
11/28/2012 | CN101756172B Method for preparing soluble plantain seed dietary fiber and application thereof |
11/28/2012 | CN101696183B (Z)-2-phenyl-3-(pyrrol-2-yl)-acrylonitrile derivative as well as salts, composition, preparation method and application thereof |
11/28/2012 | CN101648891B Aryl cyclobutyl compound and application thereof in preparing weight-losing medicine |
11/28/2012 | CN101647816B Bionic enzymatic hydrolysate for animal skins and application thereof |
11/28/2012 | CN101636391B Novel prophylactic and/or therapeutic agent for neurogenic pain |
11/28/2012 | CN101627021B Prophylactic and/or therapeutic agent for hyperlipemia |
11/28/2012 | CN101617827B Supramolecular composite of isosteviol or derivative thereof and preparation method thereof |
11/28/2012 | CN101612312B Application of Chinese medicinal composition in preparation of medicament for treating diabetic complication |
11/28/2012 | CN101525382B Method of purifying pramlintide |
11/28/2012 | CN101462994B Vitamin D derivatives |
11/28/2012 | CN101432256B Method for stabilization of reduced coenzyme Q10 |
11/28/2012 | CN101384275B Dissolution aids for oral peptide delivery comprising a biguanide |
11/28/2012 | CN101366731B Propolis flavone, preparation method and uses in treating diabetes |
11/28/2012 | CN101365490B Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same |
11/28/2012 | CN101279955B N-substituted thiamorpholine derivate as DPP-IV inhibitor and medical use thereof |
11/28/2012 | CN101189960B Method for breeding selenium-rich livestock and fowls |
11/28/2012 | CN101123964B G-protein coupled receptor(GPR116) agonists and use thereof for treating obesity and diabetes |
11/27/2012 | US8318813 Method of treating binge eating disorder |
11/27/2012 | US8318788 Layered pharmaceutical formulations |
11/27/2012 | US8318778 Urea glucokinase activators |
11/27/2012 | US8318748 Cathepsin cysteine protease inhibitors |
11/27/2012 | US8318744 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
11/27/2012 | US8318696 Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative |
11/27/2012 | US8318668 Stabilized GLP-1 analogs |
11/27/2012 | US8318667 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
11/27/2012 | US8318666 Use of leptin to treat metabolic abnormalities associated with lipoatrophy |
11/27/2012 | US8318664 Unacylated ghrelin fragments as therapeutic agent in the treatment of obesity |
11/27/2012 | US8318467 Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes |
11/27/2012 | CA2690841C Synthetic bile acid composition, method, and preparation |
11/27/2012 | CA2666612C Methods, compositions, and formulations for the treatment of thyroid eye disease |
11/27/2012 | CA2608311C Glp-1 pegylated compounds |
11/27/2012 | CA2531505C (20s)-1.alpha.-hydroxy-2-methylene-19-nor-vitamin d3 and its uses |
11/27/2012 | CA2513310C Indenoncarboxylic acids derivatives and their use for the treatment of and preventing diabetes and dyslipidaemia |